Keywords: phase, iii, studies, amgen, amg, underway, biotechnology

Phase III studies for Amgen's AMG 162 underway

Article | 16 August 2004

Print This

US biotechnology giant Amgen says the first patients have been dosedin two pivotal Phase III trials of AMG 162, its fully-human ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in